数据驱动与共识诊断轻度认知障碍的比较
研究对738名无痴呆老年人进行神经心理学聚类分析,识别出5个认知亚组,并随访约5.9年。数据驱动方法比共识诊断多分类29.5%的MCI,且在识别生物标志物异常、进展为痴呆或尸检有AD病理者方面更优。
要点
- 数据驱动方法较共识诊断提高MCI检出率29.5%。
- 混合型MCI进展痴呆风险最高,AD生物标志物阳性及病理比例最高。
- 数据驱动方法在捕捉不良结局方面优于共识诊断。
核心结论
- 数据驱动算法较共识诊断能更敏感地识别有认知下降风险的老年人。
- 识别出的MCI亚型具有不同的认知、生物标志物和神经病理特征。
研究设计与样本
- 对加州大学圣地亚哥ADRC的738名无痴呆参与者基线神经心理学数据进行聚类分析,平均年龄71.8岁。
- 生存分析评估进展为痴呆(平均随访5.9年),部分子集分析脑脊液AD生物标志物和尸检神经病理。
主要发现
- 识别出5个聚类:最优认知正常(n=130)、典型认知正常(n=204)、非遗忘型MCI(n=104)、遗忘型MCI(n=216)、混合型MCI(n=84)。
- 进展为痴呆率:混合型MCI > 遗忘型MCI > 非遗忘型MCI。
- 混合型MCI组脑脊液生物标志物阳性率和尸检AD病理比例最高。
- 数据驱动方法多分类29.5%的样本为MCI,且在捕捉生物标志物异常、进展痴呆或尸检AD病理者方面优于共识诊断。
关键数值与推荐
- 数据驱动方法分类MCI的比例比共识诊断高29.5%。
临床怎么用
- 数据驱动算法可提高MCI诊断敏感性,有助于识别高风险老年人。
- 混合型MCI患者应更密切监测认知变化和AD生物标志物。
局限性
- 生物标志物和神经病理分析仅基于部分子集。
- 样本来自单一ADRC,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Given prior work demonstrating that mild cognitive impairment (MCI) can be empirically differentiated into meaningful cognitive subtypes, we applied actuarial methods to comprehensive neuropsychological data from the University of California San Diego Alzheimer's Disease Research Center (ADRC) in order to identify cognitive subgroups within ADRC participants without dementia and to examine cognitive, biomarker, and neuropathologic trajectories. METHODS: Cluster analysis was performed on baseline neuropsychological data (n = 738; mean age 71.8). Survival analysis examined progression to dementia (mean follow-up 5.9 years). CSF Alzheimer disease (AD) biomarker status and neuropathologic findings at follow-up were examined in a subset with available data. RESULTS: Five clusters were identified: optimal cognitively normal (CN; n = 130) with above-average cognition, typical CN (n = 204) with average cognition, nonamnestic MCI (naMCI; n = 104), amnestic MCI (aMCI; n = 216), and mixed MCI (mMCI; n = 84). Progression to dementia differed across MCI subtypes (mMCI > aMCI > naMCI), with the mMCI group demonstrating the highest rate of CSF biomarker positivity and AD pathology at autopsy. Actuarial methods classified 29.5% more of the sample with MCI and outperformed consensus diagnoses in capturing those who had abnormal biomarkers, progressed to dementia, or had AD pathology at autopsy. DISCUSSION: We identified subtypes of MCI and CN with differing cognitive profiles, clinical outcomes, CSF AD biomarkers, and neuropathologic findings over more than 10 years of follow-up. Results demonstrate that actuarial methods produce reliable cognitive phenotypes, with data from a subset suggesting unique biological and neuropathologic signatures. Findings indicate that data-driven algorithms enhance diagnostic sensitivity relative to consensus diagnosis for identifying older adults at risk for cognitive decline.
引用
- Edmonds EC, Smirnov DS, Thomas KR, et al. Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes. Neurology. 2021. PMID: 34376506. doi:10.1212/WNL.0000000000012600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。